Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
Latest brief · 2026-08-10
Kidney-protecting diabetes drugs are a big theme today: GLP-1 medicines (the Ozempic family) and SGLT2 inhibitors like dapagliflozin, which looked helpful even in children. Blood pressure drugs called RAS blockers were also tied to fewer new cases of kidney disease in people with type 2 diabetes. Most of the rest of today's sweep is early research just getting started, so there are few new results yet.
Podocin Oligomerization links Slit Diaphragm Architecture and NPHS2 Genetics
The kidney's filter is built from tiny cells called podocytes, joined by a sieve called the slit diaphragm that keeps protein in the blood. This study mapped how a protein named podocin clumps together to hold that sieve in shape, and tied it to a gene (NPHS2) linked to kidney disease. It was lab work on the filter's structure, not a test in people.
Heme-induced kallikrein-kinin system activation in hemolytic uremic syndrome
In a disease called hemolytic uremic syndrome, red blood cells break apart and release a substance called heme. This lab study looked at how heme switches on a blood-clotting and inflammation system that may harm the kidneys. It was done in the lab, not in people, so it only points to a possible mechanism.
Spectrum of Anti–Factor B-Associated Glomerular Diseases in Adults
Some people make antibodies that attack part of their own immune system called factor B, which can damage the kidney's tiny filters. Researchers described which kidney diseases these antibodies cause in adults and how the patterns differ. This was an observational study, so it shows links, not proof of cause.
Self-Management Data and Disease Progression in Chronic Kidney Disease
This study follows people with chronic kidney disease who use a phone app to track blood pressure, blood sugar, medicines, and diet. Researchers want to see if steady self-tracking is linked to slower disease. It is just starting, so there are no results yet.
The role of gut microbiome disruption in the development of metabolic dysfunction-associated kidney disease.
This article reviews how an unhealthy balance of gut bacteria may help drive kidney disease linked to metabolic problems like obesity and diabetes. It pulls together existing science on the gut-kidney connection. It is a review, not a new study, so there are no new results.
Association Between Dietary Magnesium Intake and All-Cause Mortality in Patients with Chronic Kidney Disease: Insights from NHANES 1999-2018.
This study asked whether people with kidney disease who eat more magnesium live longer. It used a large U.S. health survey covering 1999 to 2018. It found a link between more magnesium in the diet and a lower risk of dying from any cause. This shows a link only — it cannot prove magnesium is the reason.
The Therapeutic Application of Epigenetic Regulation by Natural Herbal Compounds in Kidney Diseases.
This is a review of lab research on natural herbal compounds and how they might switch kidney-disease genes on or off. That on/off control is called epigenetics. It pulls together earlier work done in cells and animals, so there are no results in people yet.
Regulatory Frameworks and Technical Bottlenecks for Clinical Translation of the Bioartificial Kidney.
This lays out the rules and technical hurdles blocking the bioartificial kidney — a lab-built device meant to do a real kidney's job. It explains what still has to be solved before such a device can be tested and approved for patients. There are no results yet.
Proteomic Identification of Pig Xenoantigens for Clinical Xenotransplantation.
Scientists used protein-mapping tools to find the pig molecules that a human immune system would attack after a pig-kidney transplant. Knowing these targets could help make pig organs safer to put into people. This was lab work on pig tissue, not a test in patients.